-
UK royal finances in spotlight after Andrew's downfall
-
Diplomatic shift and elections see Armenia battle Russian disinformation
-
Undercover probe finds Australian pubs short-pouring beer
-
Epstein fallout triggers resignations, probes
-
The banking fraud scandal rattling Brazil's elite
-
Party or politics? All eyes on Bad Bunny at Super Bowl
-
Man City confront Anfield hoodoo as Arsenal eye Premier League crown
-
Patriots seek Super Bowl history in Seahawks showdown
-
Gotterup leads Phoenix Open as Scheffler struggles
-
In show of support, Canada, France open consulates in Greenland
-
'Save the Post': Hundreds protest cuts at famed US newspaper
-
New Zealand deputy PM defends claims colonisation good for Maori
-
Amazon shares plunge as AI costs climb
-
Galthie lauds France's remarkable attacking display against Ireland
-
Argentina govt launches account to debunk 'lies' about Milei
-
Australia drug kingpin walks free after police informant scandal
-
Dupont wants more after France sparkle and then wobble against Ireland
-
Cuba says willing to talk to US, 'without pressure'
-
NFL names 49ers to face Rams in Aussie regular-season debut
-
Bielle-Biarrey sparkles as rampant France beat Ireland in Six Nations
-
Flame arrives in Milan for Winter Olympics ceremony
-
Olympic big air champion Su survives scare
-
89 kidnapped Nigerian Christians released
-
Cuba willing to talk to US, 'without pressure'
-
Famine spreading in Sudan's Darfur, UN-backed experts warn
-
2026 Winter Olympics flame arrives in Milan
-
Congo-Brazzaville's veteran president declares re-election run
-
Olympic snowboard star Chloe Kim proud to represent 'diverse' USA
-
Iran filmmaker Panahi fears Iranians' interests will be 'sacrificed' in US talks
-
Leicester at risk of relegation after six-point deduction
-
Deadly storm sparks floods in Spain, raises calls to postpone Portugal vote
-
Trump urges new nuclear treaty after Russia agreement ends
-
'Burned in their houses': Nigerians recount horror of massacre
-
Carney scraps Canada EV sales mandate, affirms auto sector's future is electric
-
Emotional reunions, dashed hopes as Ukraine soldiers released
-
Bad Bunny promises to bring Puerto Rican culture to Super Bowl
-
Venezuela amnesty bill excludes gross rights abuses under Chavez, Maduro
-
Lower pollution during Covid boosted methane: study
-
Doping chiefs vow to look into Olympic ski jumping 'penis injection' claims
-
England's Feyi-Waboso in injury scare ahead of Six Nations opener
-
EU defends Spain after Telegram founder criticism
-
Novo Nordisk vows legal action to protect Wegovy pill
-
Swiss rivalry is fun -- until Games start, says Odermatt
-
Canadian snowboarder McMorris eyes slopestyle after crash at Olympics
-
Deadly storm sparks floods in Spain, disrupts Portugal vote
-
Ukrainian flag bearer proud to show his country is still standing
-
Carney scraps Canada EV sales mandate
-
Morocco says evacuated 140,000 people due to severe weather
-
Spurs boss Frank says Romero outburst 'dealt with internally'
-
Giannis suitors make deals as NBA trade deadline nears
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
J.AbuShaban--SF-PST